Low NOP group* (n=130) | High NOP group* (n=51) | p Value | |
---|---|---|---|
Demographics | |||
Age, mean (SD) | 65 (11) | 61 (11) | 0.03 |
Gender, male, n (%) | 121 (93%) | 44 (86%) | 0.15 |
Race, white, n (%) | 67 (52%) | 24 (47%) | 0.44 |
Ethnicity, Hispanic, n (%) | 36 (28%) | 14 (28%) | 0.97 |
Comorbidities | |||
Hypertension, n (%) | 102 (79%) | 34 (67%) | 0.10 |
Diabetes mellitus, n (%) | 52 (40%) | 9 (18%) | 0.004 |
Sleep apnoea, n (%) | 28 (22%) | 14 (28%) | 0.40 |
BPH, n (%) | 24 (19%) | 8 (16%) | 0.66 |
Medications | |||
Anxiolytic, n (%) | 39 (30%) | 35 (69%) | <0.0005 |
Antidepressant, n (%) | 49 (38%) | 30 (59%) | 0.01 |
Antihistamine, n (%) | 19 (15%) | 13 (26%) | 0.08 |
Analgesics, n (%) | 74 (57%) | 40 (78%) | 0.007 |
*Determined by cluster analysis.
BPH, benign prostatic hypertrophy; n, number in each group; NOP, neuropathic ocular pain.